Adams, A., Johnson, D., Longnecker, R., Sloat, B. & Pringle, J. 1990. Cdc42 and Cdc43, Two additional genes involved in budding and the establishment of cell polarity in the yeast saccharomyces cerevisiae. Journal of Cell Biology 111: 131-142.
Aggarwal, B., Banerjee, S., Bharadwaj, U. & Sung, B. 2007. Curcumin induces the degradation of cyclin E expression. Biochemical Pharmacology 73: 1024-1032.
Aggarwal, S., Takada, Y., Singh, S., Myers, J. & Aggarwal, B. 2004. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-Kb signaling. International Journal of Cancer 111: 679-692.
Amin, A., Haque, A., Rahman, M., Chen, Z., Khuri, F. & Moon Shin, D. 2015. Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways. Plos One 10: e0124218.
Baghi, N., Javidi, M.A., Babashah, S. & Sadegizadeh, M. 2014. Curcumin enhances the cisplatin-induced cytotoxicity in breast cancer stem-like cells. Nutrition and Food Sciences Research 1: 86-87.
Baharuddin, P., Satar, N., Fakiruddin, K. & Zakaria, N. 2016. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through P21 and Cyclin D1-mediated tumour cell. Oncology Reports 35: 13-25.
Bao, W., Thullberg, M., Zhang, H., Onischenko, A. & Stromblad, S. 2002. Cell attachment to the extracellular matrix induces proteasomal degradation of P21 (Cip1) via Cdc42/Rac1 Signaling. Molecular and Cellular Biology 22: 4587-4597.
Chattopadhyay, I., Biswas, K., Bandyopadhyay, U. & Banerjee, R. 2004. Turmeric and curcumin biological actions and medicinal applications. Current Science 87: 50-87.
Chen, P., Li, J., Jiang, H. & Lan, T. 2014. Curcumin reverses cisplatin resistance in cisplatin-resistant lung. Tumor Biology 36: 3591-3599.
Chen, Q., Jiao, D., Yao, Q., Yan, J., Song, J., Chen, F., Lu, G. & Zhou, J. 2012. Expression analysis of cdc42 in lung cancer and modulation. International Journal of Oncology 40: 1561-1568.
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J., Comber, H., Forman, D. & Bray, F. 2013. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer 49: 1374-1403.
Groot, P., Wu, C., Carter, B. & Munden, R. 2018. The epidemiology of lung cancer. Translational Lung Cancer Research 7: 220-233.
Hirsch, D., Shen, Y. & Wu, W. 2006. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degra-dation is correlated with inactivation of Cdc42. Cancer Research 66: 3523-3530.
Hui, Y., Jo-Hua, C., Chi-Cheng, L., Jiun-Long, Y., Tung-Yuan, L., Yang-Ching, K. & Jing-Gung, C. 2010. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress a caspase cascade and mitochondria-dependent pathways. Anticancer Research 30: 2125-2134.
Iqbal, B., Ghildiyal, A., Sahabjada, S., Arshad, M., Mahdi, A. & Tiwari, S. 2016. Antiproliferative and apoptotic effect of curcumin and TRAIL (TNF related apoptosis inducing ligand) in chronic myeloid leukaemic cells. Journal of Clinical and Diagnostic Research 10: 1-5.
Jen-Yi, L., Yee-Ming, L., Gee-Chen, C., Sung-Liang, Y., Wan-Yu, H., Jeremy, J., Huei-Wen, C. & Pan-Chyr, Y. 2011. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates P38 activation in Intestine: The versatile adjuvant for gefitinib therapy. Plos One 6(8): e23756.
Jia, Y., Li, J., Qin, Z. & Liang, Z. 2009. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. Asian Natural Products Research 11: 918-928.
Karin, Z., Trevor, L., Patrick, R., Dietmar, A. & Seyedhossein, A. 2013. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice. Plos One 8: e74924.
Khar, A., Ali, A.M., Pardhasaradhi, B.V., Begum, Z. & Anjum, R. 1999. Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. Febs Letters 445: 165-168.
Kuo, M., Huang, T. & Lin, J. 1996. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1317: 95-100.
Langer, C., Besse, B., Gualberto, A., Brambilla, E. & Soria, J. 2010. The evolving role of histology in the management of advanced non-small cell lung cancer. Journal for Clinical Oncology 28: 5311-5320.
Leu, T. & Maa, M. 2002. The molecular mechanisms for the antitumorigenic effect of curcumin. Current Medicinal Chemistry- Anti-Cancer Agents 2: 357-70.
Liu, T., Tan, Z., Jiang, L., Gu, J., Wu, X., Cao, Y., Li, M., Wu, K. & Liu, Y. 2013. Curcumin induces apoptosis in gallbladder carcinoma cell Line GBC-SD cells. Cancer Cell International 13: 13-64.
Liu, Y., Wang, Y., Zhang, Y. & et al. 2009. Abnormal expression of P120- catenin, E-cadherin, and small gtpases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer 63: 375-382.
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P. & Aggarwal, B. 2001. Curcumin downregulates cell survival mechanisms in human cancer cell lines. Oncogene 20: 7597-7609.
Notarbartoloa, M., Pomaa, P., Perria, D. & Dusoncheta, L. 2005. Antitumor effects of curcumin, alone or in combination with. Cancer Letters 224: 53-65.
Oda, Y. 1995. Inhibitory effect of curcumin on SOS functions induced by UV irradiation. Mutation Research Letters, 348: 67-73.
Pal, S., Choudhuri, T., Chattopadhyay, S., Bhattacharya, A., Datta, G., Das, T. & Sa, G. 2001. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochemical and Biophysical Research Communications 288: 658-665.
Park, B.H., Eun Lim, J., Gyun Jeon, H., Seo, S. & Moo, H. 2016. Curcumin potentiates antitumor activity of cisplatin in bladder. Oncotarget 7: 63870-63886.
Qadir, M., Parveen, A. & Ali, M. 2015. Cdc42: Role in cancer management. Chemical Biology & Drug Design 86: 432-439.
Ray, M. & Jablons, D. 2009. Lung cancer metastasis novel biological mechanisms and impact on clinical practice. Hallmarks of Metastasis. Pp.29-46.
Sahai, E. & Marshall, C. 2002. Rho-GTPases and Cancer. Nature Reviews Cancer 2: 133-142.
Shishodia, S. 2005. Curcumin inhibits constitutive NF-κB Activation, Induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochemical Pharmacology 70: 700-713.
Siddique, Ym., Aram G., Begm T., Gupta, J., & Afzal, M. 2009. Assessment of cell viability, lipid peroxidation and quantification of DNA fragmentation after the treatment of anticancerous drug mitomycin C and curcumin in cultured human blood lymphocytes. Experimental and Toxicologic Pathology 62: 503-508.
Siegel, R., Miller, K. & Jemal, A. 2019. Cancer statistics. CA: A Cancer Journal for Clinicians 69: 7-34.
Siwak, D., Shishodia, S., Aggarwal, B. & Kurzrock, R. 2005. Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐ activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway. Cancer 104: 879-890.
Vanhoefer, U., Harstrick, A., Wilke, H., Schleucher, N., Walles, H., Schriider, J. & Seeber, S. 1995. Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in Vi&O. European Journal of Cancer 31: 92-97.
Wiltshaw, E. 1979. Cisplatin in the treatment of cancer. Platinum Metals Review 23: 90-98.
Wu, Q., Chen, Y. & Li, X. 2005. Effect of curcumin on caspase 8- and caspase 9-induced apoptosis of lymphoma raji cell. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13: 624-627.
Wu, S., Hang, L., Yang, J., Chen, H., Lin, H., Chiang, J., Lu, C., Yang, J., Lai, T., Ko, Y. & Chung, J. 2010. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through er stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Research 30: 2125-2133.
Xiaolan, Z., Yuefeng, L., Huiling, S., Hao, L., Lulu, L., Lulu, H. & Wenlin, X. 2013. Mir-137 Inhibits the proliferation of lung cancer cells. Febs Letters 587: 73-81.
Xiuzhen, H., Baoshan, X., Christopher, S., Yoshinobu, O., Long, C, Lei, L. & Yan, L. 2012. Curcumin inhibits protein phosphatases 2a and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 33: 868-875.
Yang, L., Wang, L. & Zheng, Y. 2006. Gene targeting of Cdc42 and Cdc42 gap affirms the critical involvement of cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Molecular Biology of the Cell 17: 4675-4685.
Yuefeng, L., Xiaolan, Z., Wenlin, X., Dongqing, W. & Jinchuan, Y. 2013. Mir-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42. Biochemical and Biophysical Research Communications 431: 560-565.
Zugasti, O., Rul, W. & Roux, P. 2001. Raf-Mek-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Molecular and Cellular Biology 21: 6706-6717.